Page last updated: 2024-10-21

hydroxyindoleacetic acid and Cognition Disorders

hydroxyindoleacetic acid has been researched along with Cognition Disorders in 14 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)."7.725-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004)
"In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)."3.725-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004)
"Lewy body disorders, including Parkinson's disease (PD), Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), are characterized by profound central and peripheral monoaminergic dysfunction."1.48Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. ( Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y, 2018)
"Schizophrenia is associated with multiple cognitive deficits which in turn may be related to abnormal dopamine (DA) function."1.29Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. ( Apter, S; Davidson, M; Davis, KL; Harvey, PD; Kahn, RS; Keefe, RS; Mohs, RC; Neale, JM, 1994)
"In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in controls (P less than ."1.28Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. ( Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D, 1990)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's5 (35.71)18.2507
2000's3 (21.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Zee, S1
Vermeiren, Y1
Fransen, E1
Van Dam, D1
Aerts, T1
Gerritsen, MJ1
Spikman, JM1
van Laar, T1
De Deyn, PP1
Pudell, C1
Vicente, BA1
Delattre, AM1
Carabelli, B1
Mori, MA1
Suchecki, D1
Machado, RB1
Zanata, SM1
Visentainer, JV1
de Oliveira Santos Junior, O1
Lima, MM1
Ferraz, AC1
Luo, J1
Wang, T1
Liang, S1
Hu, X1
Li, W1
Jin, F1
Pomara, N1
Willoughby, LM1
Hashim, A1
Sershen, H1
Sidtis, JJ1
Wesnes, K1
Greenblatt, DJ1
Lajtha, A1
Pardon, MC1
Hanoun, N1
Perez-Diaz, F1
Joubert, C1
Launay, JM1
Christen, Y1
Hamon, M1
Cohen-Salmon, C1
Stuerenburg, HJ1
Ganzer, S1
Müller-Thomsen, T1
Leckman, JF1
Cohen, DJ1
Shaywitz, BA1
Caparulo, BK1
Heninger, GR1
Bowers, MB1
McEntee, WJ1
Mair, RG1
Langlais, PJ1
Kahn, RS1
Harvey, PD1
Davidson, M1
Keefe, RS1
Apter, S1
Neale, JM1
Mohs, RC1
Davis, KL1
Shimada, A1
Yamaguchi, K1
Yanagita, T1
Masson, H1
Popescu, I1
Strubel, D1
Cramer, H1
Kuntzmann, F1
Faustman, WO1
Faull, KF1
Whiteford, HA1
Borchert, C1
Csernansky, JG1
Hildebrand, J1
Bourgeois, F1
Buyse, M1
Przedborski, S1
Goldman, S1
Mayeux, R1
Stern, Y1
Sano, M1
Cote, L1
Williams, JB1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00004325]200 participants Observational1988-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for hydroxyindoleacetic acid and Cognition Disorders

ArticleYear
Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.
    Neurochemical research, 2004, Volume: 29, Issue:7

    Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Apolipoprotein E4; Apolipoproteins; Apolipoproteins

2004

Other Studies

13 other studies available for hydroxyindoleacetic acid and Cognition Disorders

ArticleYear
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    Journal of Parkinson's disease, 2018, Volume: 8, Issue:1

    Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differ

2018
Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised rats.
    The European journal of neuroscience, 2014, Volume: 39, Issue:2

    Topics: Animals; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Central Nervous System Agents; Cognit

2014
Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat.
    Science China. Life sciences, 2014, Volume: 57, Issue:3

    Topics: Animals; Anxiety; Brain; Cognition Disorders; Dinoprostone; Disease Models, Animal; Enzyme-Linked Im

2014
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
    Neurobiology of aging, 2004, Volume: 25, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist

2004
5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Neuro endocrinology letters, 2004, Volume: 25, Issue:6

    Topics: Aged; Alzheimer Disease; Cognition Disorders; Depression; Dopamine; Female; Homovanillic Acid; Human

2004
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Archives of general psychiatry, 1980, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Autistic Disorder; Bipolar Disorder; Child; Child, Preschool;

1980
Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
    Neurology, 1984, Volume: 34, Issue:5

    Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacet

1984
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
    Schizophrenia research, 1994, Volume: 11, Issue:3

    Topics: Adult; Cerebral Cortex; Cognition Disorders; Discrimination Learning; Dopamine; Homovanillic Acid; H

1994
Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain.
    Annals of the New York Academy of Sciences, 1996, Oct-31, Volume: 801

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Hy

1996
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
    Journal of the American Geriatrics Society, 1990, Volume: 38, Issue:1

    Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid;

1990
CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression.
    Biological psychiatry, 1990, Feb-01, Volume: 27, Issue:3

    Topics: Adult; Aged; Arousal; Cognition Disorders; Depressive Disorder; Dexamethasone; Female; Humans; Hydro

1990
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Acta neurologica Scandinavica, 1990, Volume: 81, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Cognition Disorders; Female; G

1990
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
    Neurology, 1987, Volume: 37, Issue:7

    Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid

1987